SeaStar Medical issues new unregistered warrants after $3.3 million cash exercise
SeaStar Medical set agreements for immediate cash exercise of 854,002 outstanding warrants at USD 3.866 per share. Transaction targets about USD 3.3 million gross proceeds; warrants had prior exercise prices of USD 6.38 to USD 7.62. Company to issue 1,708,004 new unregistered warrants at USD 3.616, split between five-y